Company Filing History:
Years Active: 2012
Title: Innovations of Rang-Woon Park in Heparin Conjugates
Introduction
Rang-Woon Park is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of biochemistry, particularly in the development of heparin conjugates. His work focuses on innovative methods that have potential applications in cancer treatment.
Latest Patents
Rang-Woon Park holds a patent for "Heparin conjugates and methods." This patent discloses various heparin conjugates and methods of making and using them. An illustrative heparin conjugate includes a composition wherein a bile acid is bonded to heparin through the 3-carbon of the bile acid. A spacer may be interposed between the bile acid and the heparin. Another embodiment includes a targeting moiety bonded to the heparin-bile acid conjugate through a spacer. Additionally, another illustrative heparin conjugate includes heparin covalently bonded to a sulfonated moiety, such as a naphthalene trisulfonate residue. The method of treating cancer involves administering a heparin conjugate to an individual in need thereof. Rang-Woon Park has 1 patent to his name.
Career Highlights
Rang-Woon Park is currently associated with Mediplex Corporation, a prominent company in Korea. His work at Mediplex Corporation has allowed him to explore and develop innovative solutions in the field of biochemistry.
Collaborations
Rang-Woon Park has collaborated with notable colleagues, including Youngro Byun and E Sak Lee. Their combined expertise has contributed to advancements in their research and development efforts.
Conclusion
Rang-Woon Park's contributions to the field of heparin conjugates represent a significant advancement in cancer treatment methodologies. His innovative approaches and collaborations continue to influence the landscape of biochemistry.